review Open AccessTop 1% cited
Coronaviruses — drug discovery and therapeutic options
Nature Reviews Drug Discovery · 2016 · Vol. 15(5) · pp. 327–347
Alimuddin Zumla✉(UCL Biomedical Research Centre)Jasper Fuk‐Woo Chan(Queen Mary Hospital)Esam I. Azhar(King Abdulaziz University)David S.C. Hui(Chinese University of Hong Kong)Kwok‐Yung Yuen(Queen Mary Hospital)
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesComputational Drug Discovery MethodsCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Drug discovery2019-20 coronavirus outbreakDrugCoronavirusVirologyMedicineBusinessPharmacology
MeSH terms
Antiviral AgentsHumansRespiratory Tract InfectionsCoronavirusDrug Discovery
Funding
- National Institute for Health and Care Research
- National Natural Science Foundation of China
- Food and Health Bureau
- National Institutes of Health
- Health and Medical Research Fund
Citations
1,783
FWCI
19.40
field-weighted impact
References
302
Percentile
100%
vs. same field & year
Citations per year
Cited by
Coronavirus Disease 2019–COVID-19
Clinical Microbiology Reviews · 2020 · 1,850 citations
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Nature Reviews Drug Discovery · 2020 · 1,828 citations
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Science Translational Medicine · 2017 · 1,619 citations
Approved Antiviral Drugs over the Past 50 Years
Clinical Microbiology Reviews · 2016 · 1,404 citations
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Nature Communications · 2020 · 1,802 citations
Cytokine storm induced by SARS-CoV-2
Clinica Chimica Acta · 2020 · 575 citations
COVID-19: Transmission, prevention, and potential therapeutic opportunities
Clinica Chimica Acta · 2020 · 1,046 citations
Top Concerns of Tweeters During the COVID-19 Pandemic: Infoveillance Study
Journal of Medical Internet Research · 2020 · 840 citations
References
Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset
The Journal of Infectious Diseases · 2015 · 622 citations
A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice
PLoS Pathogens · 2007 · 477 citations
SARS-Coronavirus Replication Is Supported by a Reticulovesicular Network of Modified Endoplasmic Reticulum
PLoS Biology · 2008 · 1,043 citations
Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment
Journal of General Virology · 2013 · 409 citations
Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study
The Lancet Infectious Diseases · 2013 · 1,469 citations
Lethal Infection of K18- <i>hACE2</i> Mice Infected with Severe Acute Respiratory Syndrome Coronavirus
Journal of Virology · 2006 · 1,105 citations
Effects of chloroquine on viral infections: an old drug against today's diseases
The Lancet Infectious Diseases · 2003 · 1,291 citations
Different Epidemic Curves for Severe Acute Respiratory Syndrome Reveal Similar Impacts of Control Measures
American Journal of Epidemiology · 2004 · 1,346 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.